NHS clinical trial speeds double, thanks to fresh investment and reforms, Govt claims
Britain’s NHS is getting life-changing treatments to patients faster than ever before, according to new figures.
The average time to set up a commercial clinical trial has fallen from 169 days to 122 days in just one year, a Government spokesperson said..
A system transformed
The milestone has been backed by more than £137 million in health research reforms, standardising processes across the NHS and investing in research infrastructure nationwide, the Department for Health and Social Care said.
Regulatory reviews now typically complete in under 60 days, with 99% of studies receiving approval within target timelines, the department said.
Health Innovation and Safety Minister Dr Zubir Ahmed said: “The UK has always had world-class science and outstanding NHS clinicians.
“Today’s figures show we are now matching that excellence with a system that slashes red tape to get trials up and running at the speed patients deserve.”
What it means for the West Midlands
The improvements are already having a tangible impact across the country. The West Midlands stands to benefit significantly, with the region home to major NHS research centres that are part of the national network of 35 new Commercial Research Delivery Centres, backed by over £92.5 million in funding.
NIHR Chief Executive Professor Lucy Chappell said: “By reducing unnecessary delays and strengthening delivery across the NHS, we are enabling patients to access innovative treatments far more quickly, and bringing research closer to everyday care.”
Trials that previously took the best part of a year to get off the ground are now launching within months. A cancer treatment trial for advanced bowel cancer opened in just 70 days, with a UK patient becoming the first person in Europe to receive that treatment.
Looking ahead
The government is not resting on its laurels. A target of a 14-day initial regulatory review for early-phase trials is now being pursued, which would place the UK among the fastest research environments in the world.
Richard Torbett of the ABPI said: “Today’s announcement marks an important milestone. For the UK to fulfil its potential as a global life sciences leader, it is crucial to maintain momentum in driving down trial set-up times.”
Since April 2025, the UK has recorded 29 global firsts and 54 European firsts for patient enrolment in new trials.
